search
Back to results

Ultrasound-Monitored Changes in Achilles Tendinopathy After Extracorporeal Shock Wave Therapy

Primary Purpose

Achilles Tendinopathy

Status
Completed
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
BTL-6000 FSWT
BTL-6000 FSWT with sham applicator
Sponsored by
University Hospital, Motol
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Achilles Tendinopathy focused on measuring Extracorporeal Shock Wave Therapy, Achilles Tendinopathy, Ultrasonography

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • the patient complains about Achilles tendon pain, which limits (at least partially) his quality of life during daily activities or sport, and this condition would be referred as a tendinopathy
  • the patient's other leg is asymptomatic
  • the patient is not aware of the symptomatical mechanical tendon damage in past (eg. partial or complete rupture due to injury)
  • the patient has no previous experience with extracorporeal shockwave therapy treatment

Exclusion Criteria:

  • the patient has condition which is contraindication for extracorporeal shock wave therapy treatment
  • the patient had symptomatical mechanical tendon damage in past (eg. partial or complete rupture due to injury)

Sites / Locations

  • University Hospital Motol and 2nd Faculty of Medicine, Charles University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Treatment Group (A)

Sham Group (B)

Arm Description

Group of patients with Achilles tendinopathy which are treated by focused extracorporeal shockwave therapy once a week for 5 weeks. ESWT parameters: 0,12 mJ/mm2, 10 Hz, 1300 shocks.

Group of patients with Achilles tendinopathy in which sham extracorporeal shockwave therapy is applied once a week for 5 weeks. Total applications are 5, applicated weekly. Sham ESWT parameters are same as in Group A (0,12 mJ/mm2, 10 Hz, 1300 shocks) but with modified applicator which does not allow wave transmission.

Outcomes

Primary Outcome Measures

Change in Cross-sectional Area at the Place of Maximum Tendon Width
Measured by measuring tools in ultrasound machine in cm2. In linear view is selected maximal width place, then the position of ultrasound head is rotated to horizontal view and in this view cross section area is measured.
Change in Maximum Pain in the Achilles Tendon Area
Measured by numeric rating scale in points. The values can reach 0-10 points. A higher score means worse pain.
Change in Maximum Pain in the Achilles Tendon Area (Follow up)
Measured by numeric rating scale in points. The values can reach 0-10 points. A higher score means worse pain.
Change of Ankle Dorsiflexion Range of Motion
Measured using weight-bearing lunge test in cm.

Secondary Outcome Measures

Number of Participants With Hypoechogenic Areas
Echostructure is evaluated visually by investigator using musculoskeletal ultrasound machine. Patients who have a hypoechogenic areas in the tendon are counted.
Number of Participants With Increased Thickness of Achilles Tendon
The Achilles tendon continuity in evaluated visually by investigator using musculoskeletal ultrasound machine. Patients who have a visually significant increased thickness of tendon will be counted.
Change in VISA-A Questionnaire Score
The VISA-A questionnaire is standardized questionnaire for patients with Achilles tendinopathy. The results are recorded in points (0-100 points). The higher score indicates patients better condition.
Change in Single Leg Heel Rise Test
Patient performs as many heel rises using only one leg as possible in 30 seconds or until first sign of pain in Achilles tendon area.
Change in Single Leg Hop Test
Patient performs as many hops on one leg as possible in 30 seconds or until first sign of pain in Achilles tendon area.

Full Information

First Posted
February 24, 2021
Last Updated
June 25, 2021
Sponsor
University Hospital, Motol
search

1. Study Identification

Unique Protocol Identification Number
NCT04780919
Brief Title
Ultrasound-Monitored Changes in Achilles Tendinopathy After Extracorporeal Shock Wave Therapy
Official Title
The Ultrasound-Monitored Changes in Achilles Tendinopathy After Focused Extracorporeal Shock Wave Therapy - a Randomized Sham-Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Completed
Study Start Date
February 1, 2021 (Actual)
Primary Completion Date
April 2, 2021 (Actual)
Study Completion Date
April 2, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Motol

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is designed as a randomized, placebo-controlled clinical trial in which we monitor the effects of low-energy focused extracorporeal shockwave therapy (ESWT) in patients with Achilles tendinopathy (AT). Participants will be randomly divided into two groups. ESWT according to selected parameters will be applied to Group A. Group B will receive sham ESWT. Patients in both groups will have the same program. The research for one patient lasts a total of 8 weeks (2 months) from the initial to the final examination. In the first week, there will be a clinical examination by a physiotherapist, an ultrasonographic examination, and the patient will complete a VISA-A questionnaire. At the end of the examination, the patient will be randomly assigned to group A or B and receive the first application. For the next 4 weeks, additional applications will be performed once a week. The interval between individual applications should be at least 7 days. Thus, a total of 5 applications of ESWT or sham ESWT will be performed. The final examination will take place 3 weeks after the last application and will include the same procedures as for the initial examination.
Detailed Description
This study is designed as a randomized, placebo-controlled clinical trial in which we monitor the effects of low-energy focused extracorporeal shockwave therapy (ESWT) in patients with Achilles tendinopathy (AT). Participants will be randomly divided into two groups. ESWT according to selected parameters will be applied to Group A. Group B will receive sham ESWT. Patients in both groups will have the same program. The research for one patient lasts a total of 8 weeks (2 months) from the initial to the final examination. In the initial session, there will be a clinical examination by a physiotherapist, which includes case history questions, measuring range of motion (measured by weight-bearing lunge test), functional loading tests (1-leg heel rise test, 1-leg hop test) and an ultrasonographic examination (tendon cross section area and width at the maximal tendon antero-posterior width place). In addition, the patient will complete a VISA-A questionnaire. At the end of the initial session, the patient will be randomly assigned to group A or B and receive the first application. For the next 4 weeks, additional applications will be performed once a week. The interval between individual applications should be at least 7 days. Thus, a total of 5 applications of ESWT or sham ESWT will be performed. The final examination will take place 3 weeks after the last application and will include the same procedures as for the initial examination.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Achilles Tendinopathy
Keywords
Extracorporeal Shock Wave Therapy, Achilles Tendinopathy, Ultrasonography

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants are divided into two groups - treatment and placebo.
Masking
Participant
Masking Description
Participants don't know which group (either treatment or placebo) they are in.
Allocation
Randomized
Enrollment
18 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treatment Group (A)
Arm Type
Experimental
Arm Description
Group of patients with Achilles tendinopathy which are treated by focused extracorporeal shockwave therapy once a week for 5 weeks. ESWT parameters: 0,12 mJ/mm2, 10 Hz, 1300 shocks.
Arm Title
Sham Group (B)
Arm Type
Sham Comparator
Arm Description
Group of patients with Achilles tendinopathy in which sham extracorporeal shockwave therapy is applied once a week for 5 weeks. Total applications are 5, applicated weekly. Sham ESWT parameters are same as in Group A (0,12 mJ/mm2, 10 Hz, 1300 shocks) but with modified applicator which does not allow wave transmission.
Intervention Type
Device
Intervention Name(s)
BTL-6000 FSWT
Intervention Description
Intensity 0,12 mJ/mm2, frequency 10 Hz, total number of shocks 1300.
Intervention Type
Device
Intervention Name(s)
BTL-6000 FSWT with sham applicator
Intervention Description
Intensity 0,12 mJ/mm2, frequency 10 Hz, total number of shocks 1300 - applied with modified applicator which does not allow wave transmission.
Primary Outcome Measure Information:
Title
Change in Cross-sectional Area at the Place of Maximum Tendon Width
Description
Measured by measuring tools in ultrasound machine in cm2. In linear view is selected maximal width place, then the position of ultrasound head is rotated to horizontal view and in this view cross section area is measured.
Time Frame
Change of initial values at 3 weeks follow up after last application (8th week).
Title
Change in Maximum Pain in the Achilles Tendon Area
Description
Measured by numeric rating scale in points. The values can reach 0-10 points. A higher score means worse pain.
Time Frame
Change in maximum pain in the timeframe of the last application (5th week)
Title
Change in Maximum Pain in the Achilles Tendon Area (Follow up)
Description
Measured by numeric rating scale in points. The values can reach 0-10 points. A higher score means worse pain.
Time Frame
Change in maximum pain at 3 weeks follow up after last application (8th week).
Title
Change of Ankle Dorsiflexion Range of Motion
Description
Measured using weight-bearing lunge test in cm.
Time Frame
Change of initial values at 3 weeks follow up after last application (8th week).
Secondary Outcome Measure Information:
Title
Number of Participants With Hypoechogenic Areas
Description
Echostructure is evaluated visually by investigator using musculoskeletal ultrasound machine. Patients who have a hypoechogenic areas in the tendon are counted.
Time Frame
Change of the echostructure at 3 weeks follow up after last application (8th week).
Title
Number of Participants With Increased Thickness of Achilles Tendon
Description
The Achilles tendon continuity in evaluated visually by investigator using musculoskeletal ultrasound machine. Patients who have a visually significant increased thickness of tendon will be counted.
Time Frame
Change of the tendon continuity at 3 weeks follow up after last application (8th week).
Title
Change in VISA-A Questionnaire Score
Description
The VISA-A questionnaire is standardized questionnaire for patients with Achilles tendinopathy. The results are recorded in points (0-100 points). The higher score indicates patients better condition.
Time Frame
Change of initial values at 3 weeks follow up after last application (8th week).
Title
Change in Single Leg Heel Rise Test
Description
Patient performs as many heel rises using only one leg as possible in 30 seconds or until first sign of pain in Achilles tendon area.
Time Frame
Change of initial values at 3 weeks follow up after last application (8th week)
Title
Change in Single Leg Hop Test
Description
Patient performs as many hops on one leg as possible in 30 seconds or until first sign of pain in Achilles tendon area.
Time Frame
Change of initial values at 3 weeks follow up after last application (8th week).

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: the patient complains about Achilles tendon pain, which limits (at least partially) his quality of life during daily activities or sport, and this condition would be referred as a tendinopathy the patient's other leg is asymptomatic the patient is not aware of the symptomatical mechanical tendon damage in past (eg. partial or complete rupture due to injury) the patient has no previous experience with extracorporeal shockwave therapy treatment Exclusion Criteria: the patient has condition which is contraindication for extracorporeal shock wave therapy treatment the patient had symptomatical mechanical tendon damage in past (eg. partial or complete rupture due to injury)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stanislav Machač, Mgr., Ph.D.
Organizational Affiliation
University Hospital Motol and 2nd Faculty of Medicine, Charles University
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Motol and 2nd Faculty of Medicine, Charles University
City
Prague
Country
Czechia

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Ultrasound-Monitored Changes in Achilles Tendinopathy After Extracorporeal Shock Wave Therapy

We'll reach out to this number within 24 hrs